Dr. Barry Dworkin

Alzheimer drug press release requires further scrutiny

Madely Health Headlines Commentary for March 20, 2015

[display_podcast]

Source:

Biogen’s Alzheimer’s drug slows mental decline in early study

Reference: Based on company press release. Not published

Related posts:

  1. Alzheimer drug trial failure offers much to learn and should not be seen as a dead end
  2. Can Alzheimer's cognitive decline be prevent before signs and symptoms occur? Clinical trial to look into this possibility.
  3. Lack of evidence that painkillers like naproxen are helpful for treating Alzheimer’s disease
  4. New hypothesis proposes that Alzheimer’s is principally a disorder of the immune system within the brain. This, given alleged fabricated data in paper published in Nature in 2006, linking beta-amyloid as the causative agent.